Some studies have reported that the TGFβ2 signaling pathway plays a pro-cancer role in a variety of tumors, such as highly aggressive gliomas, breast cancers, and squamous cell carcinomas (Busch et al., 2015; Zhang et al., 2017; Abraham et al., 2018). This evidence concerns the gene TGFB2 and breast carcinoma.